Brain fluid study for Parkinson's patients
Part of Brain & nervous system clinical trials.
This study uses a special MRI scan to look at fluid drainage in the brain of people with Parkinson's disease. It aims to understand how the brain cleans itself, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease using standard guidelines.
- You are able to lie still for an MRI scan.
- Your Parkinson's symptoms get better with dopamine medications.
- You do not have other conditions like diabetes, severe kidney disease, or a history of stroke or head injury.
- You have no metal implants or other reasons that would make an MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans to understand Parkinson's disease. It compares people with Parkinson's to healthy volunteers to learn how the brain changes.
This study looks at brain features linked to dementia in people who have Parkinson disease. It may help researchers understand why dementia happens in Parkinson and how it could be detected or treated in the future.
This study uses a safe, noninvasive brain stimulation method (transcranial magnetic stimulation, or TMS) to look at brain signals related to thinking and memory in people with Parkinson's disease. The goal is to find a better way to measure cognitive changes over time.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
This study uses a special PET scan to look for signs of brain inflammation in people with Parkinson's disease. It aims to understand how inflammation relates to Parkinson's and may help in developing new treatments.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
Hear when a new Glymphatic System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.